An immunomodulatory signature of responsiveness to immune checkpoint blockade therapy

Eitemau Tebyg

• Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy
  gan: Wang, Qinghua, et al.
  Cyhoeddwyd: (2020)
• The new identified biomarkers determine sensitivity to immune check-point blockade therapies in melanoma
  gan: Chen, Hao, et al.
  Cyhoeddwyd: (2019)
• Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
  gan: Zhang, Na, et al.
  Cyhoeddwyd: (2020)
• High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations
  gan: Wang, Qinghua, et al.
  Cyhoeddwyd: (2020)
• Activation of phagocytosis by immune checkpoint blockade
  gan: Li, Chia-Wei, et al.
  Cyhoeddwyd: (2018)